Prelude Therapeutics (PRLD)

AI Score

Unlock

0.81

0.04 (5.19%)

At close: Apr 17, 2025, 3:59 PM

Prelude Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	12.47M	11.13M	27.83M	24.71M	25.29M	15.9M	26.45M	18.2M	30.61M	52.02M	50.71M	51.63M	31.83M	61.42M	343.12M	362.99M	218.31M	234.79M	29.72M	-18.88M	18.88M	-15.6M
Short-Term Investments	121.14M	142.49M	152.02M	177.22M	207.64M	214.61M	228.54M	154.05M	171.12M	172.02M	195.6M	214.56M	259.4M	259.44M	n/a	n/a	n/a	n/a	n/a	37.76M	n/a	31.19M
Long-Term Investments	n/a	n/a	4.04M	4.04M	4.04M	4.04M	4.04M	17.07M	4.04M	4.04M	4.04M	4.04M	259.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	4.15M	4.45M	405K	295K	295K	12.47M	9.36M	-743K	5.38M	4.93M	309K	309K	-255.06M	n/a	n/a	n/a	301K	n/a	475K	-18.88M	n/a	-15.6M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.28M	2.76M	2.87M	3.44M	2.65M	4.41M	5.22M	3.01M	2.65M	2.85M	2.32M	n/a	n/a	5.03M	1.46M	2.03M	2.5M	3.27M	n/a	n/a	n/a	n/a
Total Current Assets	135.9M	156.39M	182.71M	205.37M	235.59M	234.92M	260.21M	175.26M	204.38M	226.89M	248.62M	269.97M	295.12M	325.9M	344.57M	365.02M	220.81M	238.06M	30.7M	18.88M	20.22M	15.6M
Property-Plant & Equipment	35.47M	36.38M	37.13M	37.4M	37.74M	7.08M	7M	6.73M	6.7M	6.46M	6.08M	6.35M	5.64M	5.32M	5.01M	4.81M	2.48M	1.62M	1.57M	n/a	1.65M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	39.62M	40.83M	41.58M	41.74M	42.08M	23.59M	20.4M	23.06M	16.12M	15.43M	10.43M	10.7M	9.98M	5.32M	5.01M	4.81M	2.78M	1.62M	2.05M	-18.88M	1.65M	-15.6M
Total Assets	175.51M	197.22M	224.29M	247.11M	277.67M	258.51M	280.61M	198.32M	220.5M	242.33M	259.06M	280.67M	305.1M	331.22M	349.58M	369.83M	223.59M	239.68M	32.75M	n/a	21.87M	n/a
Account Payables	7.73M	5.92M	6.17M	5.31M	4.58M	5.17M	5.58M	7.08M	6.78M	10.25M	6.27M	7.39M	7.84M	11.06M	6.84M	4.84M	3.92M	5.07M	3.47M	n/a	1.97M	n/a
Deferred Revenue	n/a	n/a	3M	-5.31M	14.82M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-67K	n/a	-258K	n/a
Short-Term Debt	n/a	n/a	2.74M	n/a	1.48M	475K	938K	1.39M	1.83M	1.39M	1.82M	1.86M	1.74M	1.84M	1.4M	1.4M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	9.79M	8.39M	3.35M	800K	5.13M	7.33M	4.11M	6.69M	5.58M	4.35M	2.21M	1.94M	3.27M	1.67M	2.7M	1.84M	420K	220K	n/a	n/a	n/a	n/a
Total Current Liabilities	25.64M	22.22M	23.34M	17.64M	21.83M	16.89M	15.19M	19.66M	21.7M	21.56M	15.81M	16.07M	19.2M	19.66M	14.68M	12.42M	11.38M	11.36M	5.64M	n/a	4.83M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.09M	3.15M	3.21M	3.28M	3.34M	3.36M	3.36M	3.36M	3.36M	3.36M	2.4M	2.4M	n/a	n/a	n/a	n/a	32K	15K	96.42M	n/a	66.45M	n/a
Total Long-Term Liabilities	18.41M	18.57M	18.68M	18.73M	18.75M	3.36M	3.36M	3.36M	3.36M	3.36M	2.4M	2.79M	9.58M	312K	543K	840K	32K	15K	96.42M	n/a	66.45M	n/a
Total Liabilities	44.06M	40.79M	42.02M	36.37M	40.58M	20.25M	18.55M	23.02M	25.06M	24.92M	18.21M	18.86M	19.2M	19.98M	15.22M	13.26M	11.41M	11.37M	102.06M	n/a	71.28M	n/a
Total Debt	18.02M	18.14M	18.2M	17.64M	16.89M	475K	938K	1.39M	1.83M	1.39M	1.82M	2.25M	1.74M	2.15M	1.95M	2.24M	n/a	n/a	67K	n/a	258K	n/a
Common Stock	5K	4K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	4K	4K	n/a	n/a	n/a	n/a
Retained Earnings	-583.56M	-554.83M	-522.56M	-487.82M	-456.39M	-423.31M	-392.71M	-362.28M	-334.56M	-305.92M	-275.96M	-248.59M	-219.12M	-186.28M	-155.59M	-128.73M	-107.43M	-88.18M	-71.42M	n/a	-50.5M	n/a
Comprehensive Income	35K	167K	-290K	-235K	223K	-605K	-711K	-398K	-1.69M	-2.36M	-2.29M	-2.31M	-711K	-176K	n/a	n/a	-0.00	-239.68M	-0.00	-49.41M	-556K	-22.69M
Shareholders Equity	131.46M	156.43M	182.28M	210.73M	237.09M	238.26M	262.06M	175.3M	195.44M	217.41M	240.84M	261.81M	285.9M	311.24M	334.36M	356.57M	212.18M	228.31M	-69.31M	17.03M	-49.41M	13.9M
Total Investments	121.14M	142.49M	156.06M	181.26M	207.64M	214.61M	228.54M	171.12M	171.12M	172.02M	195.6M	214.56M	259.4M	259.44M	n/a	n/a	n/a	n/a	n/a	37.76M	n/a	31.19M